TUBA1C and neoplasm: Analysis of the tumor and TME signature scores in TCGA-KIRC cohort showed that, in line with that observed in the Braun ICB cohort, the group with elevated TUBA1C expression exhibited higher scores relating to carcinogenic pathways and TME activity (Figures 3, 6G, H).